Le marché de l'embolothérapie devrait passer de 3 341,49 millions de dollars US en 2021 à 5 758,28 millions de dollars US d'ici 2028 ; on estime qu'il croîtra à un TCAC de 8,1 % de 2022 à 2028.
L'embolothérapie est une occlusion des artères en introduisant ballons, caillots sanguins, serpentins ou mousse de gel à l'aide d'un cathéter angiographique. Le cathéter aide à bloquer un vaisseau sanguin en implantant un ballon ou tout corps étranger pour traiter les ulcères hémorragiques, fermer les fistules ou les malformations artério-veineuses, dévasculariser les organes, les défauts des vaisseaux sanguins ou contrôler les hémorragies inopérables. L'embolothérapie est également utilisée pour arrêter le flux sanguin vers et autour d'une tumeur pendant la chirurgie.
Le marché de l'embolothérapie est segmenté en produit, indication de maladie, l'utilisateur final de la procédure et la géographie. Par géographie, le marché est largement segmenté en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient & Afrique et Sud & Amérique centrale. Ce rapport offre des informations et une analyse approfondie du marché en mettant l'accent sur des paramètres tels que les tendances et la dynamique du marché, ainsi que sur l'analyse concurrentielle des principaux acteurs du marché mondial.
Insights stratégiques
Régions lucratives pour le marché de l'embolothérapie
Informations sur le marché
La préférence croissante des patients pour les procédures mini-invasives stimule le marché de l'embolothérapie
Le nombre de chirurgies mini-invasives augmente car les patients préfèrent de plus en plus ces chirurgies en raison de leur douleur postopératoire plus faible, des complications postopératoires, des séjours à l'hôpital plus courts et des temps de récupération rapides. Des traitements non invasifs ou mini-invasifs sont en cours de développement comme alternatives à la chirurgie pour les patientes atteintes d'un cancer du sein à un stade précoce. Par exemple, la chimioembolisation transartérielle, également connue sous le nom de TACE, est une procédure peu invasive généralement utilisée pour traiter le carcinome hépatocellulaire. TACE est destiné aux patients atteints d'un cancer du foie asymptomatique et non résécable. La TACE peut être utilisée pour diminuer la taille de la tumeur et rendre le patient éligible à une transplantation hépatique. Il est considéré comme une évolution d'une technique anciennement appliquée appelée Embolisation artérielle transcathéter (TAE).
L'embolisation de l'artère prostatique (EPA) est également une thérapie peu invasive mise en uvre en tant que technique ambulatoire élective pour les symptômes des voies urinaires inférieures (LUTS) secondaires à l'hyperplasie bénigne de la prostate (HBP). Le nombre de patients traités par PAE a augmenté ces dernières années. Ainsi, la préférence croissante pour les procédures mini-invasives alimente la croissance du marché de l'embolothérapie.
Informations sur les produits
Basé sur le produit, le marché de l'embolothérapie est divisé en agent embolique et dispositif de support. L'agent embolique est en outre sous-segmenté en microsphères, agents emboliques liquides, bobines emboliques, systèmes de bouchons emboliques, ballonnets détachables et autres. Le dispositif de support est en outre sous-segmenté en microcathéters et fils de guidage. Le segment des agents emboliques détient la plus grande part de marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. Les principaux facteurs moteurs de la croissance du segment des agents emboliques sont l'utilisation croissante d'agents emboliques dans divers radiologie interventionnelle procédures et progrès dans les agents emboliques.
Marché de l'embolothérapie, par produit - 2022 et 2028
Informations sur les indications de maladie
< span>Sur la base de l'indication de la maladie, le marché de l'embolothérapie est segmenté en cancer, maladie vasculaire périphérique , maladie neurologique, trouble urologique et néphrologique, trouble gastro-intestinal et autres. Le cancer est en outre sous-segmenté en cancer du foie, cancer du rein et autres. Le segment du cancer devrait détenir la plus grande part de marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus rapide de 2022 à 2028. Les principaux facteurs moteurs de la croissance du segment du cancer sont l'incidence croissante du cancer dans le monde.
Informations sur les indications de maladie
Sur la base de l'indication de la maladie, le marché de l'embolothérapie est segmenté en embolisation artérielle transcathéter (ETA), la radioembolisation artérielle transcathéter (TARE)/la radiothérapie interne sélective (SIRT) et la chimioembolisation transartérielle (TACE). Le segment de l'embolisation artérielle transcathéter (TAE) détient la plus grande part de marché en 2021. De plus, le même segment devrait enregistrer le TCAC le plus rapide au cours de la période 2022-2028. Les principaux facteurs moteurs de la croissance du segment de l'embolisation artérielle transcathéter (EAT) sont la préférence croissante pour les procédures mini-invasives par les personnes âgées, la prévalence croissante des maladies chroniques et la croissance rapide de la population gériatrique.
Informations sur l'utilisateur final
< p>En fonction de l'utilisateur final, le marché de l'embolothérapie est segmenté en hôpitaux et amp ; clinique, centre de chirurgie ambulatoire et autre utilisateur final. En 2021, l'hôpital & Le segment des cliniques détient probablement la plus grande part du marché. De plus, le même segment devrait enregistrer le TCAC le plus élevé de 2022 à 2028. Les principaux facteurs moteurs de la croissance de l'hôpital & clinique sont l'adoption croissante d'interventions chirurgicales mini-invasives (y compris vasculaires, urologiques et neurologiques), une fréquentation plus élevée des patients dans les hôpitaux pour le traitement de diverses maladies telles que le cancer, un nombre croissant d'interventions d'embolisation réalisées dans ces établissements, l'adoption croissante de dispositifs d'embolothérapie avancés et de pointe pour effectuer des procédures complexes avec précision dans les grands hôpitaux, les petites cliniques et les unités de soins intensifs.
Les développements organiques tels que les lancements et les approbations de produits sont des stratégies très adoptées par les entreprises du marché de l'embolothérapie. Quelques-uns des développements clés récents du marché sont répertoriés ci-dessous :
- En avril 2022, Boston Scientific Corporation a reçu l'autorisation 510(k) de la Food and Drug Administration (FDA) des États-Unis pour la bobine détachable en fibre EMBOLD destinée à empêcher ou réduire le flux sanguin dans le système vasculaire périphérique. Le plus récent ajout au portefeuille d'oncologie interventionnelle de Boston Scientific, l'antenne fibreuse EMBOLD a été conçue pour être utilisée dans diverses procédures d'embolisation, un traitement peu invasif destiné à bloquer un ou plusieurs vaisseaux sanguins pour obstruer ou réduire le flux sanguin.
- En septembre 2021, Abbott a annoncé l'acquisition de Walk Vascular , LLC, une société de dispositifs médicaux au stade commercial avec un système de thrombectomie par aspiration mécanique peu invasif conçu pour éliminer les caillots sanguins périphériques. Les systèmes de thrombectomie périphérique de Walk Vascular seront intégrés au portefeuille de produits endovasculaires existant d'Abbott.
Profils d'entreprise
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & ; Johnson
- Medtronic
- < span>Acandis GmbH
- SSEM Mthembu Medical (Pty) Ltd
- Balt USA LLC
- Stryker< /li>
- Guerbet LLC
- Terumo Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.
The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.
The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.
The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.
The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period
The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period
The List of Companies - Embolotherapy Market
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson Consumer Inc
- Medtronic
- Acandis GmbH
- Terumo Corporation
- Balt USA LLC
- Stryker Corporation
- Guerbet LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Aug 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)